UK Nurse's Death Linked To Weight Loss Jab

Nurse’s death linked to approved weight-loss drug
The death of a nurse from North Lanarkshire has been linked to the use of a weight-loss drug recently approved for use on the NHS. Susan McGowan, 58, took two low-dose injections of tirzepatide, known under the brand name Mounjaro, over the course of about two weeks before her death on 4 September.
Weight loss jab linked to death of NHS nurse
A nurse’s death has been linked to a weight loss drug which is approved for use on the NHS.Susan McGowan, 58, died on Sept 4 and had recently taken two doses of the weight loss jab Mounjaro.The drug,
Nurse dies after taking new NHS weight loss jab in first confirmed fatality linked to obesity drugs
A nurse has tragically died after receiving a weight loss injection in what is believed to be the first confirmed fatality linked to the drugs. Susan McGowan, 58, had taken two doses of Mounjaro, which makes people feel fuller sooner, before her death in September. The jabs are available on the NHS, but Ms McGowan purchased hers privately.
Patients Are Suing Over Alleged Side Effects of Weight-Loss Drugs
These drugs are collectively known as GLP-1 agonists because they mimic the body’s natural hormone GLP-1, which regulates appetite and digestion. The medications control blood sugar and help people eat less,
What UK’s first Mounjaro-linked death means for future of weight-loss jabs
Susan McGowan took two doses of tirzepatide, sold under the brand name Mounjaro, before she died on 4 September
Weight loss drugs UK: The different types of weight loss drugs explained as nurse's death linked to Mounjaro
Tirzepatide, known under the brand name Mounjaro is prescribed for type 2 diabetes, but has been shown in clinical trials to be effective for weight loss. It has been recommended as a weight loss drug for adults, with proposals for the phased launch of it on the NHS being set out by NICE.
Nurse becomes first UK death linked to NHS-approved weight-loss jab Mounjaro
A weight drug recently legalised in the UK contributed to the death of a 58-year-old nurse, according to a new report.
First death connected to weight loss jabs approved by NHS as nurse dies after two doses
Susan McGowan, 58, is thought to have become the first fatality connected to Mounjaro, the "King Kong" of weight loss jabs
UK Nurse's Death Linked To Weight Loss Jab: Report
The death of a nurse has been linked to a weight loss jab due to be assessed by the UK government as a way of easing pressure on the overburdened state-run National Health Service, the BBC reported on Friday.
Scots nurse’s death linked to weight-loss jab Mounjaro approved on NHS
The death of a Scots nurse has been linked to an approved weight loss injection which is available on NHS. Susan McGowan, from North Lanarkshire, took two low-dose injections of tirzepatide, known under the brand name Mounjaro,
Nurse's death becomes first in the UK to be linked to weight-loss jab
Susan McGowan, 58, from Lanarkshire, died after taking two low-dose injections of tirzepatide, known under the brand name Mounjaro.
Nurse who tried Mounjaro becomes first confirmed UK death linked to NHS weight loss jabs
Weight loss injections can be purchased from any registered pharmacy in the UK but buyers are required to enter ...
tyla1d
Mounjaro explained as Adam Lambert speaks out on drastic weight loss and why he stopped taking Ozempic
Mounjaro explained as Adam Lambert speaks out on Instagram live about his drastic weight loss and why he stopped taking ...
Customs agents in Cincinnati seize unapproved weight loss drugs
Customs and Border Protection agents in Cincinnati have seized shipments of unapproved weight loss drugs arriving from ...
Are weight loss jabs like Mounjaro and Wegovy still the answer to Britain's obesity crisis?
The NHS rollout of appetite suppressing injections has been thrown into doubt after what is believed to be the first confirmed death linked to the controversial drugs ...
FDA adds new warning to weight loss drugs including Wegovy
The U.S. Food and Drug Administration has added a new warning to drugs including Ozempic and Wegovy, cautioning that patients taking the drugs may be at a higher risk of inhaling gastric contents into ...